DE:63V Stock Latest News
Company AnnouncementsVerici Dx backs U.S. national plan to transform kidney care1w ago
Company AnnouncementsVerici Dx wins biomarker testing role in Asahi Kasei kidney transplant trial1w ago
Company AnnouncementsVerici Dx Raises £8.5m Through AIM Placing and Retail Offer2w ago
Company AnnouncementsVerici Dx Raises £8.75m and Restores AIM Trading After Capital Access Window2w ago
Company AnnouncementsVerici Dx Calls General Meeting to Approve New Share Issuance After Fundraising3w ago
Company AnnouncementsVerici Dx Opens WRAP Retail Offer Alongside £8.5m Placing3w ago
Company AnnouncementsVerici Dx launches £8m share placing to fund U.S. transplant diagnostics push3w ago
Company AnnouncementsVerici Dx to Tap AIM Capital Access Window for New Equity Raise1M ago- Company AnnouncementsVerici Dx boosts Tutivia growth and expands transplant diagnostics footprint1M ago
Company AnnouncementsVerici Dx to Launch AI-Driven Transplant Genetic Test in Q4 20261M ago
Company AnnouncementsVerici Dx Gains Olink Certification to Expand Proteomics and Biomarker Services2M ago
- Company AnnouncementsVerici Dx accelerates Tutivia rollout as revenues rise and U.S. transplant test adoption grows4M ago
- Company AnnouncementsVerici Dx Wins New York Approval, Securing Nationwide U.S. Access for Tutivia Transplant Test4M ago
Company AnnouncementsVerici Dx gains shareholder backing for major share issue and LSE admission4M ago
Company AnnouncementsVerici Dx Raises £2.6m Through Placing and WRAP Retail Offer4M ago
Company AnnouncementsVerici Dx calls shareholder meeting to approve new share issuance after fundraising4M agoCompany AnnouncementsVerici Dx raises £2.5m in heavily dilutive share placing and plans retail offer5M ago